Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AL101
AL101
Research Ayala's ex-BMS drug shows promise in triple-negative breast cancer
Fierce Biotech
Sun, 06/2/19 - 01:28 pm
ASCO 2019
Ayala Pharmaceuticals
Novartis
triple negative breast cancer
AL101
Novartis powers Notch cancer biotech Ayala to $30M series B
Fierce Biotech
Wed, 05/29/19 - 10:28 am
Novartis
Ayala Pharmaceuticals
AL101
adenoid cystic carcinoma